FMT from patients with RA into the ABX-treated mice resulted in depression-like behavior, changed gut microbiota composition, elevated levels of IL-6 and TNF-α, and downregulated levels of synaptic proteins in the PFC. The gene discussed is TNF; the disease is depressive symptom measurement.